Developer docs
API playgroundTry for free, no card

Search company profiles

Shenzhen Pengai Medical Beauty Hospital

Full company profile

uuid0006b4c

Namestring
Shenzhen Pengai Medical Beauty Hospital
Legal namestring
Aesthetic Medical International Holdings Group Limited
Websiteurl
aihgroup.net
Company typeenum
Public
Founded yearint
1997
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersNanshan, China
HQ citystring
Nanshan
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical aesthetics services, surgical cosmetic treatments, non-surgical aesthetic procedures, aesthetic medical centers, beauty healthcare services
Industry2 codes
1Plastics / Cosmetic & Dermatologic Surgery Centers
CodeHLAFAIAKPrimaryYes
2Medical Spas (Medi-Spas)
CodeHSALAFABPrimaryNo
NAICS code2 codes
  • Offices of Physicians (except Mental Health Specialists)621111
  • Beauty Salons812112
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Aesthetic Medical Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Aesthetic Medical Services
TypeOne Time License
Description

Revenue generated from providing aesthetic medical services including surgical aesthetic treatments, non-surgical aesthetic treatments, general medical services, and other aesthetic services directly to consumers at treatment centers across mainland China.

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Shenzhen Pengai Medical Beauty Hospital operates physical treatment centers across major mainland China cities, providing one-stop aesthetic medical services including surgical aesthetic treatments (plastic surgery), non-surgical aesthetic treatments (injectables, laser, minimally invasive cosmetic services), general medical services, and other aesthetic services. Services are delivered directly to individual consumers through treatment centers concentrated in the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta area.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

AIH (Shenzhen Pengai Medical Beauty Hospital) operates as a leading provider of aesthetic medical services in China, offering a comprehensive one-stop service model. The company provides an integrated portfolio of services including surgical aesthetic treatments (plastic surgery procedures), non-surgical aesthetic treatments (minimally invasive procedures such as injectables and laser treatments), general medical services, and other aesthetic services. The company operates through treatment centers spread across major cities in mainland China, with major focus on the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta area, leveraging over 20 years of clinical experience.

Product and service4 records
1Surgical Aesthetic Treatments
CategoryAesthetic Medical Services - Surgical
Description

Surgical procedures for aesthetic enhancements including plastic surgery and related invasive treatments, delivered to individual consumers through AIH's treatment centers in mainland China.

2Non-surgical Aesthetic Treatments
CategoryAesthetic Medical Services - Non-Surgical
Description

Non-invasive aesthetic procedures including injectables, laser treatments, and other minimally invasive cosmetic services, delivered to individual consumers.

3General Medical Services
CategoryGeneral Healthcare Services
Description

General medical healthcare services offered alongside aesthetic treatments at AIH's treatment centers.

4Other Aesthetic Services
CategoryAesthetic Medical Services - Other
Description

Additional aesthetic medical services complementing surgical and non-surgical treatments under AIH's one-stop service model.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

One of the largest aesthetic medical chains in mainland China with multi-city clinic operations offering surgical and non-surgical aesthetic procedures—directly comparable to AIH in business model, geography, and service mix.

TypeEmerging player
Description

China's leading online aesthetic medical platform that connects consumers to clinics and offers its own light-aesthetic services—comparable as an aesthetic services competitor that diverts patient demand from clinic chains like AIH.

3Aimeike (iKang Aesthetic / AIMIKE)
TypeDirect peer
Description

Established Chinese aesthetic medical group with multiple clinics offering surgical and non-surgical procedures across major cities—directly comparable clinic-chain competitor in the same domestic market.

TypeDirect peer
Description

Major Chinese aesthetic medical chain operating numerous clinics nationwide providing plastic surgery and non-invasive aesthetic services—directly comparable as a multi-city aesthetic hospital competitor.

TypeRegional player
Description

Multi-location aesthetic clinic operator in select international markets offering surgical and non-surgical aesthetics—comparable in service model and clinical positioning, though geographically distinct.

TypeBroad incumbent
Description

Largest U.S. specialist in body contouring and aesthetic procedures with national clinic network—broad incumbent in surgical aesthetics with comparable multi-clinic operating model and consumer positioning.

TypeDirect peer
Description

Multi-location Chinese aesthetic medical group specializing in plastic surgery and dermatology—directly comparable in service mix and tier-1/2 city footprint to AIH.

TypeBroad incumbent
Description

Largest U.S. provider of non-surgical aesthetic services (laser hair removal, injectables) with nationwide clinic footprint—comparable as a multi-clinic consumer aesthetic services chain.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Shenzhen Pengai Medical Beauty Hospital

Aesthetic Medical Servicesaihgroup.net

Shenzhen Pengai Medical Beauty Hospital firmographics

Firmographics
Name
Shenzhen Pengai Medical Beauty Hospital
Legal name
Aesthetic Medical International Holdings Group Limited
Website
https://aihgroup.net
Company type
Public
Founded year
1997
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Shenzhen Pengai Medical Beauty Hospital industry classification

Industry
Product category
Aesthetic Medical Services
NAICS
Offices of Physicians (except Mental Health Specialists) (621111), Beauty Salons (812112)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Plastics / Cosmetic & Dermatologic Surgery Centers (HLAFAIAK)
akta.pro secondary industry
Medical Spas (Medi-Spas) (HSALAFAB)

Keywords

  • Medical aesthetics services
  • Surgical cosmetic treatments
  • Non-surgical aesthetic procedures
  • Aesthetic medical centers
  • Beauty healthcare services

Where Shenzhen Pengai Medical Beauty Hospital is headquartered

Location

Headquarters

HQ city
Nanshan
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Shenzhen Pengai Medical Beauty Hospital business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Aesthetic Medical Services: Revenue generated from providing aesthetic medical services including surgical aesthetic treatments, non-surgical aesthetic treatments, general medical services, and other aesthetic services directly to consumers at treatment centers across mainland China.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Shenzhen Pengai Medical Beauty Hospital product offering

Product offering

Core offering

Shenzhen Pengai Medical Beauty Hospital operates physical treatment centers across major mainland China cities, providing one-stop aesthetic medical services including surgical aesthetic treatments (plastic surgery), non-surgical aesthetic treatments (injectables, laser, minimally invasive cosmetic services), general medical services, and other aesthetic services. Services are delivered directly to individual consumers through treatment centers concentrated in the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta area.

Product overview

AIH (Shenzhen Pengai Medical Beauty Hospital) operates as a leading provider of aesthetic medical services in China, offering a comprehensive one-stop service model. The company provides an integrated portfolio of services including surgical aesthetic treatments (plastic surgery procedures), non-surgical aesthetic treatments (minimally invasive procedures such as injectables and laser treatments), general medical services, and other aesthetic services. The company operates through treatment centers spread across major cities in mainland China, with major focus on the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta area, leveraging over 20 years of clinical experience.

Differentiator

Problem solved

Functional benefit

Products and services

  • Surgical Aesthetic Treatments Surgical procedures for aesthetic enhancements including plastic surgery and related invasive treatments, delivered to individual consumers through AIH's treatment centers in mainland China.
  • Non-surgical Aesthetic Treatments Non-invasive aesthetic procedures including injectables, laser treatments, and other minimally invasive cosmetic services, delivered to individual consumers.
  • General Medical Services General medical healthcare services offered alongside aesthetic treatments at AIH's treatment centers.
  • Other Aesthetic Services Additional aesthetic medical services complementing surgical and non-surgical treatments under AIH's one-stop service model.

Companies that use Shenzhen Pengai Medical Beauty Hospital

Customer profile

Segments1 record

Ideal customer profiles1 record

Shenzhen Pengai Medical Beauty Hospital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Shenzhen Pengai Medical Beauty Hospital partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves9 records

Expansion highlights4 records

Shenzhen Pengai Medical Beauty Hospital competitors and assessment

Company assessment

Direct peers

  • Yestar Healthcare Group: One of the largest aesthetic medical chains in mainland China with multi-city clinic operations offering surgical and non-surgical aesthetic procedures—directly comparable to AIH in business model, geography, and service mix.
  • Aimeike (iKang Aesthetic / AIMIKE): Established Chinese aesthetic medical group with multiple clinics offering surgical and non-surgical procedures across major cities—directly comparable clinic-chain competitor in the same domestic market.
  • Meilianmei Medical Cosmetology (Meili Yiyuan): Major Chinese aesthetic medical chain operating numerous clinics nationwide providing plastic surgery and non-invasive aesthetic services—directly comparable as a multi-city aesthetic hospital competitor.
  • Lido Plastic Surgery Hospital: Multi-location Chinese aesthetic medical group specializing in plastic surgery and dermatology—directly comparable in service mix and tier-1/2 city footprint to AIH.

Emerging players

  • SoYoung International (New Oxygen): China's leading online aesthetic medical platform that connects consumers to clinics and offers its own light-aesthetic services—comparable as an aesthetic services competitor that diverts patient demand from clinic chains like AIH.

Regional players

  • The Cosmetic Surgery Clinic: Multi-location aesthetic clinic operator in select international markets offering surgical and non-surgical aesthetics—comparable in service model and clinical positioning, though geographically distinct.

Broad incumbents

  • Sono Bello: Largest U.S. specialist in body contouring and aesthetic procedures with national clinic network—broad incumbent in surgical aesthetics with comparable multi-clinic operating model and consumer positioning.
  • Ideal Image: Largest U.S. provider of non-surgical aesthetic services (laser hair removal, injectables) with nationwide clinic footprint—comparable as a multi-clinic consumer aesthetic services chain.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Shenzhen Pengai Medical Beauty Hospital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Shenzhen Pengai Medical Beauty Hospital leadership team

Management profile

Number of profiles

Profiles15 records

Shenzhen Pengai Medical Beauty Hospital subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Shenzhen Pengai Medical Beauty Hospital funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Shenzhen Pengai Medical Beauty Hospital M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shenzhen Pengai Medical Beauty Hospital

What does Shenzhen Pengai Medical Beauty Hospital do?

Shenzhen Pengai Medical Beauty Hospital operates physical treatment centers across major mainland China cities, providing one-stop aesthetic medical services including surgical aesthetic treatments (plastic surgery), non-surgical aesthetic treatments (injectables, laser, minimally invasive cosmetic services), general medical services, and other aesthetic services. Services are delivered directly to individual consumers through treatment centers concentrated in the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta area.

Is Shenzhen Pengai Medical Beauty Hospital a public or private company?

Shenzhen Pengai Medical Beauty Hospital is a public company. It is classified as public and is currently operating.

When was Shenzhen Pengai Medical Beauty Hospital founded?

Shenzhen Pengai Medical Beauty Hospital was founded in 1997. It employs 1,001 to 5,000 people.

Where is Shenzhen Pengai Medical Beauty Hospital based?

Shenzhen Pengai Medical Beauty Hospital is headquartered in Nanshan, China, in the Asia region.

How does Shenzhen Pengai Medical Beauty Hospital make money?

One revenue line is on record: aesthetic Medical Services.

Who are Shenzhen Pengai Medical Beauty Hospital's main competitors?

Direct peers on record are Yestar Healthcare Group, Aimeike (iKang Aesthetic / AIMIKE), Meilianmei Medical Cosmetology (Meili Yiyuan) and Lido Plastic Surgery Hospital. SoYoung International (New Oxygen) is listed as an emerging player. The Cosmetic Surgery Clinic is listed as a regional player. Broad incumbents are Sono Bello and Ideal Image.

Does Shenzhen Pengai Medical Beauty Hospital have an API?

No public API is recorded for Shenzhen Pengai Medical Beauty Hospital.

What industry is Shenzhen Pengai Medical Beauty Hospital in?

Shenzhen Pengai Medical Beauty Hospital's product category is Aesthetic Medical Services. Its primary akta.pro industry code is HLAFAIAK, Plastics / Cosmetic & Dermatologic Surgery Centers, with a secondary code of HSALAFAB, Medical Spas (Medi-Spas). Its NAICS code is 621111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireOTC Markets Group Welcomes Aesthetic Medical International Holdings Group Ltd. to OTCQXAesthetic Medical International Holdings Group Ltd. qualified to trade on OTCQX Best Market under the symbol PAIYY, upgrading from the Pink market. The company, a leading provider of aesthetic medical services in China, began trading today. U.S. investors can access financial disclosures and real-time quotes on otcmarkets.com.GlobeNewswireAesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings PanelAesthetic Medical International Holdings Group received a Nasdaq Hearings Panel decision to delist its securities on May 17, 2024, due to failure to meet continued listing conditions. The company expects trading suspension on May 21, 2024, and plans to quote ADSs on OTC Markets, with no appeal filed.GlobeNewswireAesthetic Medical International to Announce FY2023 Annual Report on April 25, 2024Aesthetic Medical International Holdings Group Limited will release its FY2023 annual report after the U.S. market closes on April 25, 2024. The company, known as Peng'ai, operates aesthetic medical treatment centers across mainland China, focusing on the Guangdong-Hong Kong-Macau Greater Bay area and the Yangtze River Delta.GlobeNewswireAesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination From Nasdaq Staff and Intention to Request a Hearing before the Nasdaq Hearings PaAesthetic Medical International Holdings Group (AIH) will request a hearing before the Nasdaq Hearings Panel after Nasdaq staff determined it failed to regain compliance with the minimum bid price rule. The company received a notification on March 6, 2024, that it is not eligible for a second 180-calendar day grace period. The hearing request will stay further action, and securities remain eligible to trade pending the hearing's conclusion.GlobeNewswireAesthetic Medical International Holdings Group Ltd. Received a Letter of Expected Delisting Determination From Nasdaq Staff and Requested a Hearing before the Nasdaq Hearings PanelAesthetic Medical International Holdings Group requested a Nasdaq hearing to extend its equity compliance, after Nasdaq staff expected delisting. The company expects to regain compliance via a RMB170 million investment by Hainan Oriental Jiechuang Partnership, pending ODI approval.GlobeNewswireAesthetic Medical International Files Annual Report on Form 20-F for Fiscal Year 2021Aesthetic Medical International Holdings Group Limited filed its annual report on Form 20-F for fiscal year 2021 with the SEC on May 13, 2022. The report contains audited consolidated financial statements and is available on the SEC website and the company's investor relations site.GlobeNewswireAesthetic Medical International Holdings Group Limited Announces Change in Certified Public AccountantAesthetic Medical International Holdings Group Limited appointed Union Power HK as its independent registered public accounting firm, effective January 28, 2022, replacing PricewaterhouseCoopers Zhong Tian LLP. The firm is PCAOB-registered and will conduct audits under PCAOB standards. The company is working with both firms to ensure a seamless transition.GlobeNewswireAesthetic Medical International Holdings Group Limited Reports Second Quarter and First Half of 2021 Unaudited Financial ResultsAesthetic Medical International Holdings Group reported Q2 2021 revenue of RMB224.0 million, up 34.4% year-over-year, and H1 2021 revenue of RMB434.5 million, up 68.6%. Adjusted EBITDA turned to a profit of RMB14.7 million in Q2 and RMB35.2 million in H1, reversing prior losses. The company plans to divest underperforming hospitals and clinics by year-end.GlobeNewswireAesthetic Medical International Holdings Group Limited Announces USD$15.1 Million Private Placement with Lafang China Co., LtdAesthetic Medical International Holdings Group Limited entered a definitive share subscription agreement with Lafang China Co., Ltd. to raise $15.1 million through a private placement of 5,329,410 ordinary shares at $8.50 per ADS. The company intends to use the proceeds for business development and working capital, with closing expected within four months.GlobeNewswireAesthetic Medical International Holdings Group Limited Announces Changes in its Committee CompositionAesthetic Medical International Holdings Group Limited announced resignations of three committee members: Mr. Tsang Eric Chi Wai from all three committees, Mr. Xue Hongwei from the Nominating Committee, and Mr. Lu Feng from the Compensation and Nominating Committees. Dr. Zhou Pengwu will chair the Nominating Committee, and Ms. Cathy Peng will chair the Compensation Committee and join the Audit and Nominating Committees.